September 13, 2023 – Page 4

Guidance for the 2023/24 financial year

Written by Customer Service on September 13, 2023. Posted in Public Companies.

ANNOUNCEMENT NO. 242 13 September 2023 Guidance for the 2023/24 financial year ChemoMetec has today approved the annual report for 2022/23, including the guidance for 2023/24, which is considered inside information. For 2023/24, ChemoMetec expects revenue in the range of DKK 400-435 million (2022/23: DKK 442.3 million) and EBITDA in the range of DKK 200-220 (2022/23: DKK 251.0 million). The annual report for 2022/23, which is released along with this announcement, sets out the underlying assumptions applied in the preparation of the guidance for 2023/24. Additional information Rasmus Kofoed, CEO Tel.: (+45) 26 72 68 19 Niels Høy Nielsen, CFO Tel.: (+45) 25 51 87 24 About ChemoMetec A/S ChemoMetec develops, manufactures and markets instruments for cell counting and a wide range of other measurements. ChemoMetec’s instruments...

Mesa Laboratories, Inc. to Announce Second Quarter Results on November 6, 2023

Written by Customer Service on September 13, 2023. Posted in Public Companies.

LAKEWOOD, Colo., Sept. 13, 2023 (GLOBE NEWSWIRE) — Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the second quarter of fiscal year 2024 at approximately 8:00 A.M. Eastern time on Monday, November 6, 2023. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services through four divisions (Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions) to help our customers ensure product integrity, increase patient and worker safety, and improve the quality of life throughout the world. For more information about the Company,...

First American Uranium Provides Exploration Plan Update with 4 Drill Target Areas & Redrafted Maps for Red Basin Uranium/Vanadium Property

Written by Customer Service on September 13, 2023. Posted in Public Companies.

Red Basin Project is ~250 miles north of America’s only operating uranium mill Drill target areas coincide with 1000+ historic holes drilled by Gulf Oil Corporation Presence of uranium/vanadium deposits indicate potential to become advanced stage project Vancouver, British Columbia, Sept. 13, 2023 (GLOBE NEWSWIRE) — First American Uranium Inc. (CSE: URM) (FSE: IOR) (the “Company”) is pleased to provide redrafted project maps and updates to the Company’s exploration plan for its Red Basin Uranium/Vanadium Property in Catron County, New Mexico, USA. The project, which consists of 26 optioned lode claims totaling ~537 acres (~217 hectares), is ~250 miles (~402 km) north of the only operating uranium mill in America. While the original exploration plan for the Red Basin Project was filed in 2013, First American Uranium’s...

Fnac Darty decides the withdrawal of the offering of €300 million senior bond issue due January 2029

Written by Customer Service on September 13, 2023. Posted in Public Companies.

Ivry-sur-Seine, France —September 13, 2023 Fnac Darty decides the withdrawal of the offering of €300 million senior bond issue due January 2029 Following its press release of September 12, 2023, Fnac Darty decides, today, the withdrawal of the offering of €300 million senior bond issue due January 2029, given current market conditions not enough attractive. Fnac Darty benefits from a solid financial structure, with no short-term maturities and no immediate refinancing needs. Indeed, in the absence of the issue, the Delayed-Draw Term Loan (DDTL), an undrawn bank credit line of €300 million dedicated to the refinancing of outstanding May 2024 senior bonds, is maintained in its entirety. The DDTL has an initial maturity of December 2025, with a possible extension to 2027, upon lenders’ approval. *** About Fnac DartyOperating in 12 countries,...

GRIP Investments Limited and John Carswell Announces Holdings in Canso Select Opportunities Corporation

Written by Customer Service on September 13, 2023. Posted in Mergers And Acquisitions.

TORONTO, Sept. 13, 2023 (GLOBE NEWSWIRE) — GRIP Investments Limited (“GRIP Investments”) and John Carswell announced today that GRIP Investments (a corporation majority beneficially owned and controlled by John Carswell) filed an early warning report with respect to Class B Subordinate Voting Shares (“Class B SVS”) of Canso Select Opportunities Corporation (TSX: CSOC) (the “Issuer”). On September 8, 2023, GRIP Investments purchased 137,131 Class B SVS at a price of $2.50 per Class B SVS for aggregate purchase price of $342,827.50 (the “Acquisition”). Immediately prior to the Acquisition, GRIP Investments beneficially owned or controlled directly (i) 717,815 Class A Multiple Voting Shares (“Class A MVS”) representing approximately 45.33% of the 1,583,660 issued and outstanding Class A MVS, Class A MVS are convertible to Class B...

Exor Press Release – Tender Offer Launch

Written by Customer Service on September 13, 2023. Posted in Public Companies.

THIS PRESS RELEASE IS NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN AUSTRALIA, CANADA, JAPAN, OR ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW. Amsterdam, 13 September 2023 EXOR ANNOUNCES THE LAUNCH OF A TENDER OFFER TO REPURCHASE UP TO €750 MILLION IN ORDINARY SHARES AS PART OF ITS NEW €1 BILLION SHARE BUYBACK PROGRAM Exor N.V. (“Exor” or the “Company”) announces the launch of a tender offer to purchase ordinary shares with a nominal value of EUR 0.01 each in the share capital of Exor N.V. (each an “Ordinary Share”, and together the “Ordinary Shares”), executed via a reverse “Dutch auction”, for an aggregate consideration up to (and including) €750 million to Qualifying Shareholders (as defined below) (the “Tender Offer”). The...

Exor Press Release – H1 2023 Results

Written by Customer Service on September 13, 2023. Posted in Earnings Releases And Operating Results.

Amsterdam, 13 September 2023 EXOR DELIVERS 23% GROWTH IN NAV PER SHARE IN H1, OUTPERFORMING MSCI BY 11 p.p. €1 BILLION BUYBACK PROGRAM ANNOUNCED WITH TENDER OFFER AT UP TO 10% PREMIUM Exor reports NAV of €34.2 billion at 30 June 2023. NAV per share increased 22.8% over the first half of 2023, while outperforming the MSCI World Index by 11.3 p.p., mainly driven by the market performance of Listed Companies. Net debt was €0.1 billion at 30 June 2023, from a net cash position of €0.8 billion at 31 December 2022, mainly driven by cash deployment into Companies, Investments and share buyback, partially offset by dividends received. The Board of Directors approved today a €1 billion buyback program. Up to €750 million of this will be executed in the form of a Tender Offer to be launched on 14 September 2023, at a premium of up to 10%. €...

HighCo: Half-Year 2023 Results

Written by Customer Service on September 13, 2023. Posted in Earnings Releases And Operating Results.

Aix-en-Provence, 13 September 2023 (6 p.m.) HIGHCO: H1 2023 BUSINESS ACTIVITY, EARNINGS AND PROFITABILITY IN LINE WITH EXPECTATIONS; ADJUSTED GUIDANCE FOR 2023 H1 2023 business volumes in line with expectations H1 2023 gross profit of €38.43 m, up 0.3% on a reported basis and LFL1. Growth in digital businesses (H1 up 3.4% LFL) and decline in offline businesses (H1 down 5.5% LFL). Slight business growth in France (H1 up 0.6% LFL) and less significant decline in International business (H1 down 1.7% LFL). Slight increase in first-half results Headline PBIT2 of €10 m, up slightly by 0.4%. Operating margin2 of 26%, stable. Operating income of €9.52 M, up 1.7%. Adjusted attributable net income3 of €6.32 m, up 6.9%. Adjusted earnings per share (EPS)3 of €0.31, up 9%. Financial position remains strong Operating cash flow of €7.48 m (excluding...

Global Anastomosis Devices Market Size to Reach USD 5.85 Billion in 2030 | Emergen Research

Written by Customer Service on September 13, 2023. Posted in Mergers And Acquisitions.

Advancements in the number of cardiovascular surgical research activities is driving market revenue growth Vancouver, Sept. 13, 2023 (GLOBE NEWSWIRE) — The global anastomosis devices market size reached USD 3.58 Billion in 2021 and is expected to register a revenue CAGR of 5.6% during the forecast period, according to latest analysis by Emergen Research. The market is primarily driven by two trends: an increase in surgical procedures and a rise in gastrointestinal and cardiovascular diseases. The World Health Organization (WHO) reports that Cardiovascular Diseases (CVDs) are the leading cause of death globally, accounting for 17.9 million deaths annually. Gain access to a complimentary copy of our latest sample report @ https://www.emergenresearch.com/request-sample/1414 The need for enhanced research and development is driven...

Results of Akropolis Group’s shopping centres grow – in the first half of this year, they welcomed almost 21 million visitors, whereas the turnover of tenants exceeded EUR 543 million

Written by Customer Service on September 13, 2023. Posted in Public Companies.

In the first half of 2023, the five shopping centres operated in Lithuania and Latvia by Akropolis Group, a developer and manager of shopping and entertainment centres in the Baltic States, were visited by almost 21 million visitors, 13.5% more than in the same period last year. Growing visitor footfall positively affected the turnover of tenants of the shopping centres, which reached EUR 543 million and was 12.2% higher than a year earlier. “The growth in tenant turnover in the first half of this year reflects the positive response of Akropolis visitors to the new brand stores that constantly open in the shopping centres and to the renovation of the stores of favourite brands, as well as to the entertainment and services offered. We are pleased that we are meeting both the expectations of our visitors to choose from a wide range of goods...

Day: September 13, 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice